Engineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacy

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Chen, Feng ^a   Hong, Hao ^a   Shi, Sixiang ^b   Goel, Shreya ^b   Valdovinos, Hector F ^c   Hernandez, Reinier ^c   Theuer, Charles P ^d   Barnhart, Todd E ^c   Cai, Weibo ^a,b,c,e  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b University of Wisconsin Madison   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d TRACON Pharmaceuticals Inc   (United States)

^e UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAROTUXIMAB; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY; NANOCAPSULE; NANOCONJUGATE; SILICON DIOXIDE;

CHEMISTRY; CRYSTALLIZATION; DRUG POTENTIATION; EXPERIMENTAL NEOPLASM; HUMAN; MATERIALS TESTING; METABOLISM; NANOPORE; PARTICLE SIZE; POROSITY; PROCEDURES; SURFACE PROPERTY; TUMOR CELL LINE; ULTRASTRUCTURE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CELL LINE, TUMOR; CRYSTALLIZATION; DRUG SYNERGISM; HUMANS; MATERIALS TESTING; NANOCAPSULES; NANOCONJUGATES; NANOPORES; NEOPLASMS, EXPERIMENTAL; PARTICLE SIZE; POROSITY; RECEPTORS, CELL SURFACE; SILICON DIOXIDE; SURFACE PROPERTIES;

EID: 84901773165     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05080     Document Type: Article

References (42)

1. Vallet-Regi, M., Rámila, A., del Real, R. P. & Pérez-Pariente, J. A new property of MCM-41: drug delivery system. Chem Mater 13, 308-311 (2000).
2. Tarn, D. et al.Mesoporous Silica Nanoparticle Nanocarriers: Biofunctionality and Biocompatibility. Acc Chem Res 46, 792-801 (2013).
3. Chen, Y., Chen, H. & Shi, J. In vivo bio-safety evaluations and diagnostic/ therapeutic applications of chemically designed mesoporous silica nanoparticles. Adv Mater 25, 3144-3176 (2013).
4. Tang, F., Li, L. & Chen, D. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater 24, 1504-1534 (2012).
5. Li, L. L. et al. In Vivo Delivery of Silica Nanorattle Encapsulated Docetaxel for Liver Cancer Therapy with Low Toxicity and High Efficacy. ACS Nano 4, 6874-6882 (2010).
6. Liu, H. et al. Targeting gold nanoshells on silica nanorattles: a drug cocktail to fight breast tumors via a single irradiation with near-infrared laser light. Adv Mater 24, 755-761 (2012).
7. Wang, X. et al. Perfluorohexane-encapsulated mesoporous silica nanocapsules as enhancement agents for highly efficient high intensity focused ultrasound (HIFU). Adv Mater 24, 785-791 (2012).
8. Shi, S., Chen, F. & Cai, W. Biomedical applications of functionalized hollow mesoporous silica nanoparticles: focusing on molecular imaging. Nanomedicine (Lond) 8, 2027-2039 (2013).
9. Luo, Z. et al. Engineering a hollow nanocontainer platform with multifunctional molecular machines for tumor-targeted therapy in vitro and in vivo. ACS Nano 7, 10271-10284 (2013).
10. Fan,W. P. et al. Rattle-structured multifunctional nanotheranostics for synergetic chemo-/radiotherapy and simultaneous magnetic/luminescent dual-mode imaging. J Am Chem Soc 135, 6494-6503 (2013).
11. Chen, Y. et al. Multifunctional mesoporous composite nanocapsules for highly efficient MRI-guided high-intensity focused ultrasound cancer surgery. Angew Chem Int Ed 50, 12505-12509 (2011).
12. Rosen, L. S. et al. A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer. Clin Cancer Res 18, 4820-4829 (2012).
13. Chen, F. et al. In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles. ACS Nano 7, 9027-9039 (2013).
14. Seon, B. K. et al. Endoglin-targeted cancer therapy. Curr Drug Deliv 8, 135-143 (2011).
15. Fonsatti, E., Nicolay, H. J., Altomonte, M., Covre, A. &Maio, M. Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours. Cardiovasc Res 86, 12-19 (2010).
16. Fang, X., Chen, C., Liu, Z., Liu, P. & Zheng, N. A cationic surfactant assisted selective etching strategy to hollow mesoporous silica spheres. Nanoscale 3, 1632-1639 (2011).
17. Chen, Y. et al. Hollow/Rattle-Type Mesoporous Nanostructures by a Structural Difference-Based Selective Etching Strategy. ACS Nano 4, 529-539 (2010).
18. Taylor, K. M. et al.Mesoporous silica nanospheres as highly efficient MRI contrast agents. J Am Chem Soc 130, 2154-2155 (2008). (Pubitemid 351287981)
19. Arriagada, F. J. & Osseo-Asare, K. Synthesis of Nanosize Silica in a Nonionic Water-in-Oil Microemulsion: Effects of the Water/Surfactant Molar Ratio and Ammonia Concentration. J Colloid Interface Sci 211, 210-220 (1999). (Pubitemid 29394621)
20. Choi, H. S. et al. Targeted zwitterionic near-infrared fluorophores for improved optical imaging. Nat Biotechnol 31, 148-153 (2013).
21. Alauddin, M. M. Positron emission tomography (PET) imaging with 18F-based radiotracers. Am J Nucl Med Mol Imaging 2, 55-76 (2012).
22. Gambhir, S. S. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2, 683-693 (2002). (Pubitemid 37328919)
23. Temma, T. & Saji, H. Radiolabelled probes for imaging of atherosclerotic plaques. Am J Nucl Med Mol Imaging 2, 432-447 (2012).
24. Holland, J. P., Cumming, P. & Vasdev, N. PET radiopharmaceuticals for probing enzymes in the brain. Am J Nucl Med Mol Imaging 3, 194-216 (2013).
25. Hong, H. et al. In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene. ACS Nano 6, 2361-2370 (2012).
26. Hong, H., Zhang, Y., Sun, J. & Cai, W. Molecular imaging and therapy of cancer with radiolabeled nanoparticles. Nano Today 4, 399-413 (2009).
27. Chen, K., Li, Z. B., Wang, H., Cai, W. & Chen, X. Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots. Eur J Nucl Med Mol Imaging 35, 2235-2244 (2008).
28. Chen, F. & Cai, W. Tumor Vasculature Targeting: A Generally Applicable Approach for Functionalized Nanomaterials. Small 10, 1887-1893 (2014).
29. Gao, Y., Cui, Y., Chan, J. K. & Xu, C. Stem cell tracking with optically active nanoparticles. Am J Nucl Med Mol Imaging 3, 232-246 (2013).
30. Wu, Y., Zhang, W., Li, J. & Zhang, Y. Optical imaging of tumor microenvironment. Am J Nucl Med Mol Imaging 3, 1-15 (2013).
31. Wang, K., He, X., Yang, X. & Shi, H. Functionalized silica nanoparticles: a platform for fluorescence imaging at the cell and small animal levels. Acc Chem Res 46, 1367-1376 (2013).
32. Yuan, L. et al. Preparation of pH-Responsive Mesoporous Silica Nanoparticles and Their Application in Controlled Drug Delivery. J Phys Chem C 115, 9926-9932 (2011).
33. Guo, J. et al. Image-guided and tumor-targeted drug delivery with radiolabeled unimolecular micelles. Biomaterials 34, 8323-8332 (2013).
34. Hong, H. et al. In vivo targeting and positron emission tomography imaging of tumor vasculature with (66)Ga-labeled nano-graphene. Biomaterials 33, 4147-4156 (2012).
35. Shi, S. et al. Tumor vasculature targeting and imaging in living mice with reduced graphene oxide. Biomaterials 34, 3002-3009 (2013).
36. Xiao, Y. et al. Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imaging. Biomaterials 33, 3071-3082 (2012).
37. Yang, X. et al. cRGD-functionalized, DOX-conjugated, and (6)(4)Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. Biomaterials 32, 4151-4160 (2011).
38. Liu, Z. et al. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotechnol 2, 47-52 (2007). (Pubitemid 46210038)
39. Zhang, Y. et al. PET imaging of CD105/endoglin expression with a (6)(1)/ (6)(4)Cu-labeled Fab antibody fragment. Eur J Nucl Med Mol Imaging 40, 759-767 (2013).
40. Zhang, Y. et al. Positron Emission Tomography and Near-Infrared Fluorescence Imaging of Vascular Endothelial Growth Factor with Dual-Labeled Bevacizumab. Am J Nucl Med Mol Imaging 2, 1-13 (2012).
41. Hong, H. et al. Positron emission tomography imaging of tumor angiogenesis with a (61/64)Cu-labeled F(ab')(2) antibody fragment. Mol Pharm 10, 709-716 (2013).
42. Hong, H. et al. Multimodality Imaging of Breast Cancer Experimental Lung Metastasis with Bioluminescence and aMonoclonal Antibody Dual-Labeled with (89)Zr and IRDye 800CW. Mol Pharm 9, 2339-2349 (2012).